899
Participants
Start Date
April 4, 2023
Primary Completion Date
January 17, 2025
Study Completion Date
January 17, 2025
Heart Failure medications
There is no treatment allocation. Patients are allocated to the respective cohort based on the treating physician enrolling them in the study. Patients are treated according to the local prescribing information and routine medical practice.
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
Novartis Investigative Site, Potsdam
Novartis Investigative Site, Stahnsdorf
Novartis Investigative Site, Hoppegarten
Novartis Investigative Site, Rostock
Novartis Investigative Site, Brüel
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Winsen
Novartis Investigative Site, Winsen
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Lübeck
Novartis Investigative Site, Wismar
Novartis Investigative Site, Kiel
Novartis Investigative Site, Kiel
Novartis Investigative Site, Papenburg
Novartis Investigative Site, Wedemark
Novartis Investigative Site, Löhne
Novartis Investigative Site, Kassel
Novartis Investigative Site, Biedenkopf
Novartis Investigative Site, Fulda
Novartis Investigative Site, Rotenburg an der Fulda
Novartis Investigative Site, Braunschweig
Novartis Investigative Site, Wolfsburg
Novartis Investigative Site, Magdeburg
Novartis Investigative Site, Schönebeck
Novartis Investigative Site, Jerichow
Novartis Investigative Site, Duessledorf
Novartis Investigative Site, Düsseldorf
Novartis Investigative Site, Remscheid
Novartis Investigative Site, Moers
Novartis Investigative Site, Kleve
Novartis Investigative Site, Münster
Novartis Investigative Site, Stadtlohn
Novartis Investigative Site, Osnabrück
Novartis Investigative Site, Ingelheim
Novartis Investigative Site, Siegen
Novartis Investigative Site, Hagen
Novartis Investigative Site, Brilon
Novartis Investigative Site, Frankfurt
Novartis Investigative Site, Bad Vilbel
Novartis Investigative Site, Bad Homburg
Novartis Investigative Site, Breuberg
Novartis Investigative Site, Kleinblittersdorf
Novartis Investigative Site, Homburg
Novartis Investigative Site, Bexbach
Novartis Investigative Site, Bechhofen
Novartis Investigative Site, Ludwigshafen
Novartis Investigative Site, Frankenthal
Novartis Investigative Site, Speyer
Novartis Investigative Site, Kaiserslautern
Novartis Investigative Site, Kaiserslautern
Novartis Investigative Site, Heidelberg
Novartis Investigative Site, Heidelberg
Novartis Investigative Site, Stuttgart
Novartis Investigative Site, Ludwigsburg
Novartis Investigative Site, Göppingen
Novartis Investigative Site, Rudersberg
Novartis Investigative Site, Rastatt
Novartis Investigative Site, Bruchsal
Novartis Investigative Site, Müllheim
Novartis Investigative Site, Farchant
Novartis Investigative Site, Aichach
Novartis Investigative Site, Ulm
Novartis Investigative Site, Giengen an der Brenz
Novartis Investigative Site, Ehingen
Novartis Investigative Site, Dinkelsbühl
Novartis Investigative Site, Amberg
Novartis Investigative Site, Schwandorf in Bayern
Novartis Investigative Site, Coburg
Novartis Investigative Site, Würzburg
Novartis Investigative Site, Kitzingen
Novartis Investigative Site, Bad Neustadt an der Saale
Novartis Investigative Site, Erfurt
Novartis Investigative Site, Urbach
Novartis Investigative Site, Chemnitz
Novartis Investigative Site, Pirna
Novartis Investigative Site, Berlin
Novartis Investigative Site, Bitterfeld-Wolfen
Novartis Investigative Site, Coswig
Novartis Investigative Site, Dessau
Novartis Investigative Site, Dresden
Novartis Investigative Site, Dresden
Novartis Investigative Site, Freiberg
Novartis Investigative Site, Gera
Novartis Investigative Site, Halle S
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Limbach-Oberfrohna
Novartis Investigative Site, Markkleeberg
Novartis Investigative Site, Radebeul
Novartis Investigative Site, Wermsdorf
Novartis Investigative Site, Wiesbaden
Novartis Investigative Site, Wittenberg
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY